Longevitytech.fund logo

Longevitytech.fund

North America, Florida, United States, Boca Raton

Description

Longevitytech.fund is a specialized venture capital firm based in Boca Raton, United States, dedicated to investing globally in pre-seed and seed-stage startups developing technologies aimed at extending healthy human lifespans. The fund's investment thesis centers on supporting innovative companies at the intersection of biotechnology, healthcare, and deep tech, with a strong emphasis on scientific rigor and groundbreaking research. They adopt a hands-on approach, actively collaborating with their portfolio companies to foster growth and navigate the complex landscape of longevity science.

The firm is known for its focused strategy within the burgeoning longevity sector, identifying early-stage ventures with high potential for disruptive impact. Longevitytech.fund typically deploys initial checks ranging from $100,000 to $500,000, providing crucial early capital to help founders validate their concepts and achieve key milestones. Their commitment extends beyond mere capital, offering strategic guidance and leveraging their network to support the development of groundbreaking solutions.

With a portfolio that includes over 25 investments, Longevitytech.fund has established itself as an active and prominent player in the longevity investment space. Their global reach allows them to identify promising opportunities worldwide, contributing to the advancement of technologies that could significantly improve human health and extend vitality. The fund's strategic location in Florida also places it within a growing hub for biotech and health innovation.

Investor Profile

Longevitytech.fund has backed more than 45 startups, with 1 new investments in the last 12 months alone. The firm has led 13 rounds, about 29% of its total and boasts 2 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Seed, Convertible Note, Pre Seed rounds (top funding stages).
  • Majority of deals are located in United States, United Kingdom, The Netherlands.
  • Strong thematic focus on Biotechnology, Health Care, Life Science.
  • Led 1 rounds in the past year.
  • Typical check size: $100K – $500K.

Stage Focus

  • Seed (44%)
  • Convertible Note (27%)
  • Pre Seed (20%)
  • Series Unknown (4%)
  • Equity Crowdfunding (2%)
  • Series A (2%)

Country Focus

  • United States (69%)
  • United Kingdom (18%)
  • The Netherlands (4%)
  • Germany (2%)
  • Greece (2%)
  • Israel (2%)
  • Finland (2%)

Industry Focus

  • Biotechnology
  • Health Care
  • Life Science
  • Health Diagnostics
  • Pharmaceutical
  • Biopharma
  • Therapeutics
  • Medical Device
  • Artificial Intelligence (Ai)
  • Medical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Longevitytech.fund frequently co-invest with?

Emerging Longevity Ventures
North America, Florida, United States, West Palm Beach
Co-Investments: 2
TI
Asia, Shanghai, China, Shanghai
Co-Investments: 2
Y Combinator
North America, California, United States, Mountain View
Co-Investments: 2
Oxford Technology Management
Europe, Oxfordshire, United Kingdom, Oxford
Co-Investments: 2
UK Innovation & Science Seed Fund
Europe, Oxfordshire, United Kingdom, Harwell
Co-Investments: 2
TF
Europe, England, United Kingdom, London
Co-Investments: 2
APEX Ventures
Europe, Wien, Austria, Vienna
Co-Investments: 2
R42 Group
North America, California, United States, Stanford
Co-Investments: 4
Empirical Ventures
Europe, Bristol, City of, United Kingdom, Bristol
Co-Investments: 2
Khosla Ventures
North America, California, United States, Menlo Park
Co-Investments: 2

Which angels does Longevitytech.fund often collaborate with?

Balaji Srinivasan
Asia, Central Region, Singapore, Singapore
Shared Deals: 1
YN
Europe, Zurich, Switzerland, Zürich
Shared Deals: 1
BL
North America, California, United States, San Francisco
Shared Deals: 1
PB
North America, California, United States, Mountain View
Shared Deals: 1
MB
North America, California, United States, Los Angeles
Shared Deals: 1
RH
Europe, Berlin, Germany, Berlin
Shared Deals: 1

What are some of recent deals done by Longevitytech.fund?

Klothea Bio

Miami, Florida, United States

Klothea Bio is well known for its powerful anti-aging capabilities, such as tumor suppression, neuroprotection, and antioxidative actions.

BiotechnologyLife SciencePharmaceutical
SeedNov 25, 2024
Yuva Biosciences

Birmingham, Alabama, United States

Yuva Biosciences uses mitochondrial science to develop cosmeceuticals and pharmaceuticals.

Biotechnology
SeedFeb 20, 2024
Amount Raised: $7,500,000
MitoRx Therapeutics

Harwell, Oxfordshire, United Kingdom

MitoRx Therapeutics is a biotechnology company developing novel therapeutics that reverse mitochondrial dysfunction.

BiotechnologyTherapeutics
SeedDec 13, 2023
Amount Raised: $5,048,523
Rejuvenation Technologies

Mountain View, California, United States

Rejuvenation Technologies is a biotechnology company that developed nucleoside-modified TERT mRNA to safely and rapidly extend telomeres.

BiotechnologyHealth Care
SeedSep 6, 2023
Amount Raised: $10,600,000
SiPhox Health

Burlington, Massachusetts, United States

SiPhox Health builds diagnostic infrastructure both for the home and the central lab.

Health CareHealth DiagnosticsMedical Device
SeedJul 19, 2023
Amount Raised: $10,000,000
Cosmica Biosciences

San Francisco, California, United States

Cosmica Biosciences primarily engages in accelerating drug discovery for longevity.

BiotechnologyLife ScienceSpace Travel
Pre SeedJun 26, 2023
Cleara Biotech

Utrecht, Utrecht, The Netherlands

Cleara is developing therapeutics to eliminate senescent cells.

Biotechnology
SeedSep 28, 2022
Amount Raised: $2,500,000
Remedium Bio

Needham, Massachusetts, United States

Remedium Bio is a gene therapy company focused on the development of highly innovative treatments for a broad range of diseases.

BiotechnologyHealth CareTherapeutics
SeedAug 15, 2022
Amount Raised: $2,300,000
Senisca

Exeter, Devon, United Kingdom

Senisca is a biotech spinout company that creates a new generation of oligonucleotide-based interventions.

BiotechnologyHealth Care
SeedJun 9, 2022
Amount Raised: $2,498,545
MitoRx Therapeutics

Harwell, Oxfordshire, United Kingdom

MitoRx Therapeutics is a biotechnology company developing novel therapeutics that reverse mitochondrial dysfunction.

BiotechnologyTherapeutics
SeedApr 25, 2022